22.05.2014 - The price of Pfizer cannot overcome the resistance
The stock price of pharmaceutical company Pfizer continues to consolidate below the strong level 30.00 dollars per share. It is worth noting that in the case of price fixing below this level, as well as the strong resistance inclined line, the quotes of the company will likely continue to decline within the downward channel to 27.00 dollars per share. Growth is limited by the upper boundary of the descending channel. We expect a further reduction of price in the medium term.